最新资讯： ARKG
ARK Genomic Revolution ETF — 主流媒体中涉及该基金的文章，按最新发布时间排序。每条链接均跳转至原始发布页面。
过去7天内暂无文章引用该基金。我们只展示真实且附有链接的文章，绝不以占位内容填充。 浏览全部市场资讯 →
提及该内容的数据简报 ARKG 自主研发
ARKG jumps 4.27% on August 25, now up 65.72% YTD
ARK Genomic Revolution ETF (ARKG) advanced 4.27% to $50.06 on August 25, with AUM of approximately $1.6 billion. The fund has now gained 65.72% year-to-date, making the day's move incremental relative to a strong broader run. ARKG is an actively managed ETF focused on companies involved in genomics, gene editing, and related biotechnology.
ETF Explorer · Aug 25ARKG rises 10.46% on August 19, up 49.15% YTD
ARK Genomic Revolution ETF closed at $47.73 on August 19, gaining 10.46% on the day, with AUM of approximately $1.56 billion. The fund tracks genomics and biotechnology equities. The single-day move extends a year-to-date gain of 49.15%, making it one of the stronger performers in the thematic equity space in 2025.
ETF Explorer · Aug 19